PLRZ
Polyrizon Ltd.NASDAQHealthcare$12.08-4.20%ClosedMarket Cap: $13.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.94
P/S
0.00
EV/EBITDA
-2.80
DCF Value
$0.81
FCF Yield
-25.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-26.1%
ROA
-19.2%
ROIC
-17.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-3.8M | $-3.2M | $-1.96 | — |
| FY 2025 | $0.00 | -Infinity% | $-6.2M | $-3.3M | $-2.07 | — |
| Q2 2025 | $0.00 | -Infinity% | $1.2K | $-88.50 | $-0.06 | — |
| Q1 2025 | $0.00 | NaN% | $1.2K | $-88.50 | $-0.06 | — |
| Q4 2024 | $0.00 | -Infinity% | $477.50 | $-957.0K | $-36.30 | — |
| FY 2024 | $0.00 | -Infinity% | $-1.3M | $-1.5M | $-134.14 | — |
| Q3 2024 | $0.00 | NaN% | $477.50 | $-478.50 | $-36.30 | — |
| Q2 2024 | $0.00 | -Infinity% | $-347.0K | $-588.0K | $-29.95 | — |
| Q1 2024 | $0.00 | NaN% | $173.50 | $-294.00 | $-29.95 | — |
| Q4 2023 | $0.00 | -Infinity% | $-310.0K | $-409.0K | $0.00 | — |
| FY 2023 | $0.00 | -Infinity% | $-635.0K | $-600.0K | $0.00 | — |
| Q2 2023 | $0.00 | -Infinity% | $-325.0K | $-191.0K | $0.00 | — |